ResMed Inc. – Consensus Indicates Potential 18.6% Upside
ResMed Inc. found using ticker (RMD) now have 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 276 and 222 with the average target price sitting at 253.33. With the stocks previous close at 213.69 this is indicating there is a potential upside of 18.6%. The day 50 moving average is 230.48 and the 200 day moving average is 230.45. The market cap for the company is $31,410m. Visit the company website at: https:||www.resmed.com [stock_market_widget type="chart" template="basic" color="green" assets="RMD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $37,236m based on the market concensus. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. – Consensus Indicates Potential 18.6% Upside
ResMed Inc. found using ticker (RMD) now have 6 analysts covering the stock with the consensus suggesting a rating of ''Buy''. The range between the high target price and low target price is between 276 and 222 with the average target price sitting at 253.33. With the stocks previous close at 213.69 this is indicating there is a potential upside of 18.6%. The day 50 moving average is 230.48 and the 200 day moving average is 230.45. The market cap for the company is $31,410m. Visit the company website at: https:||www.resmed.com [stock_market_widget type="chart" template="basic" color="green" assets="RMD" range="6mo" interval="1d" axes="true" cursor="true" api="yf"] The potential market cap would be $37,236m based on the market concensus. ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.